Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

205
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

179
Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

Red Blood Cells Alloimmunization and Autoimmunization in Multitransfused Thalassemia Patients in South of Iran

Pages

  40-47

Abstract

 Background: Recurrent Blood Transfusion is a common treatment in patients with Thalassemia. The development of antibodies against red blood cell (RBC) antigens complicates RBC cross-matching, enhances the in vivo destruction of transfused cells, accelerates tissue iron overloading, delays the provision of safe transfusion, and reduces health-related quality of life. Materials and Methods: In total, 516 Thalassemia patients with a mean age of 18. 5 years were included in this cross-sectional study in Mashhad University of Medical Sciences, Razavi Khorasan Province, Iran, in cooperation with the Abu Rayhan Special Medical Center and Hormozgan Blood Transfusion Organization between June 2015 and May 2016. The detection and identification of alloantibodies were done using 3 screen cells and 11 panel cells, respectively. To detect autoantibodies, auto-control was performed using polyspecific Coombs (IgG + C3d) standard method. Results: Alloantibodies and autoantibodies were observed in 16 (3. 1%) and 21 (4. 1%) patients, respectively. Among patients with alloantibodies, 2 patients (12. 5%) developed 3 antibodies (Anti-c, E, P1; Anti-c, E, K), 1 patient (6. 25%) developed 2 antibodies (Anti-D, C), and 13 patients developed 1 antibody (4 patients Anti-D (25%); 3 Anti-K (18. 75%); 2 Anti-E (12. 5%); 2 Anti-C (12. 5%); 1 Anti-Jka (6. 25%); and 1 Anti-Jkb (6. 25%)). A statistically significant correlation between patient age (P = 0. 031), age of splenectomy (P = 0. 006), Rh(D) (P = 0. 001), leukoreduction of RBCs (P = 0. 043), and type of disease (P = 0. 006) with RBC Alloimmunization was seen. Conclusions: This study emphasized the need for the determination of RBC minor antigens, especially for Rh, Kell, and Kidd blood group systems, before the first transfusion and transfusion of antigen-matched blood. In addition, transfusion of prestorage leukoreduced packed cells is recommended for these patients.

Cites

  • No record.

    • References

  • No record.

    • Cite

    APA: Copy

    Homeirani, Farough, KERAMATI, MOHAMMAD REZA, SADEGHIAN, MOHAMMAD HADI, Mozaffari, Zeynab, & MORADI ZARMEHRI, AZAM. (2019). Red Blood Cells Alloimmunization and Autoimmunization in Multitransfused Thalassemia Patients in South of Iran. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, 9(1), 40-47. SID. https://sid.ir/paper/320717/en

    Vancouver: Copy

    Homeirani Farough, KERAMATI MOHAMMAD REZA, SADEGHIAN MOHAMMAD HADI, Mozaffari Zeynab, MORADI ZARMEHRI AZAM. Red Blood Cells Alloimmunization and Autoimmunization in Multitransfused Thalassemia Patients in South of Iran. IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY[Internet]. 2019;9(1):40-47. Available from: https://sid.ir/paper/320717/en

    IEEE: Copy

    Farough Homeirani, MOHAMMAD REZA KERAMATI, MOHAMMAD HADI SADEGHIAN, Zeynab Mozaffari, and AZAM MORADI ZARMEHRI, “Red Blood Cells Alloimmunization and Autoimmunization in Multitransfused Thalassemia Patients in South of Iran,” IRANIAN JOURNAL OF PEDIATRIC HEMATOLOGY AND ONCOLOGY, vol. 9, no. 1, pp. 40–47, 2019, [Online]. Available: https://sid.ir/paper/320717/en

    Related Journal Papers

  • No record.

    • Related Seminar Papers

  • No record.

    • Related Plans

  • No record.

    • Recommended Workshops






    Move to top